doi:10.3969/j.issn.1673-8640.2021.01.019

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 14

[1]	LEE J S,PARK Y M,HA K Y,et al.Preoperative anxiety about spinal surgery under general anesthesia[J]. Eur Spine J,2016,25(3):698-707.
[2]	LIU S,QI Q,CHEN Z,et al.Polymicrobial and monomicrobial infections after spinal surgery:a retrospective sudy to determine which infection is more severe[J]. Asian Spine J,2017,11(3):427-436.
[3]	王朝君,冯艳红,张晓丽,等. 不同时间使用抗菌药物与脊椎术后感染临床相关性分析[J]. 中华医院感染学杂志,2016,26(20):4672-4674.
[4]	中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志,2001,81(5):314-320.
[5]	KATO S,CHIKUDA H,OHYA J,et al.Risk of infectious complications associated with blood transfusion in elective spinal surgery-a propensity score matched analysis[J]. Spine J,2016,16(1):55-60.
[6]	WON Y I,KIM C H,CHUNG C K,et al.The use fibrin sealant after spinal intradural tumor surgery:is it necessary?[J]. Korean J Spine,2016,13(1):24-29.
[7]	ZHANG L M,REN L,ZHAO Z Q,et al.Surgical treatment for bacterial meningitis after spinal surgery:a case report[J]. Medicine(Baltimore),2017,96(11):e6099.
[8]	FAWI H M T,SABA K,CUNNINGHAM A,et al. Venous thromboembolism in adult elective spinal surgery:a tertiary centre review of 2 181 patients[J]. Bone Joint J,2017,99-B(9):1204-1209.
[9]	刘少强,齐强,陈仲强,等. 临床诊断与病原确诊脊柱术后感染的临床特征对比[J]. 中国矫形外科杂志,2016,24(11):1006-1009.
[10]	赵卫卫,肖林林,刘秀芬,等. 术前外周血中性粒细胞/淋巴细胞比值在乳腺癌诊断中的作用[J]. 检验医学,2018,33(3):209-212.
[11]	KOAKUTSU T,SATO T,AIZAWA T,et al.Postoperative changes in presepsin level and values predictive of surgical site infection after spinal surgery:a single center,prospective observational study[J]. Spine(Phila Pa 1976),2018,43(8):578-584.
[12]	TUREL M K,KEROLUS M,DEUTSCH H.The role of minimally invasive spine surgery in the management of pyogenic spinal discitis[J]. J Craniovertebr Junction Spine,2017,8(1):39-43.
[13]	SMITH T J,BAUER A T,KALLIES K J,et al.Outcomes of anterior exposure for spinal surgery at an independent academic medical center[J]. WMJ,2017,116(1):15-21.
[14]	徐翔,何庆文,肖才文. IL-35抑制炎症反应和T细胞反应性减轻变应性鼻炎的机制研究[J]. 中国免疫学杂志,2017,33(9):1386-1391.

感染部位	例数/例	百分比/%
肺部	17	48.57
尿路	10	28.57
切口浅层	5	14.27
椎间隙	3	8.58

感染部位	例数/例	百分比/%
肺部	17	48.57
尿路	10	28.57
切口浅层	5	14.27
椎间隙	3	8.58

菌株名称	菌株数/株	百分比/%
革兰阳性菌	17	44.74
金黄色葡萄球菌	8	21.05
表皮葡萄球菌	6	15.79
溶血性葡萄球菌	3	7.90
革兰阴性菌	20	52.63
大肠埃希菌	11	28.95
铜绿假单胞菌	6	15.79
鲍曼不动杆菌	2	5.26
阴沟肠杆菌	1	2.63
真菌	1	2.63
白念珠菌	1	2.63
合计	38	100

菌株名称	菌株数/株	百分比/%
革兰阳性菌	17	44.74
金黄色葡萄球菌	8	21.05
表皮葡萄球菌	6	15.79
溶血性葡萄球菌	3	7.90
革兰阴性菌	20	52.63
大肠埃希菌	11	28.95
铜绿假单胞菌	6	15.79
鲍曼不动杆菌	2	5.26
阴沟肠杆菌	1	2.63
真菌	1	2.63
白念珠菌	1	2.63
合计	38	100

组别	例数	NLR	DD/ （ng/mL）	PLR
感染组	35	4.33±1.03	528.17±43.60	126.88±41.76
非感染组	325	1.89±0.47	317.44±40.89	189.03±35.04
t值		25.013	28.782	9.777
P值		0.000	0.000	0.000

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 14

Related Articles 15

Recommended Articles

Metrics

组别	例数	IL-35/ （pg/mL）	IL-10/ （μg/L）	PCT/ （μg/L）
感染组	35	41.69±10.47	12.10±3.68	4.79±0.40
非感染组	325	78.10±10.88	31.14±7.26	0.36±0.11
t值		18.878	15.291	154.001
P值		0.000	0.000	0.000

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.